Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$440.3K
15.22K shares
What this filing means
SCHOENBERG MARK plans to sell 15.22K shares of UROGEN PHARMA LTD. valued at approximately $440.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/9/2026ACC: 0001976408-26-000558
Officer· Chief Medical Officer
Since Jan 2019
15.22K
Shares to sell
$440.3K
Approx. market value
30K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
6/8/2023
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/8/2023 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$300.0K
5/8/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
5.22K
Market value
$140.2K
6/8/2026
Total
Units
15.22K
Value
$440.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/8/2026 | 10K | $300.0K | — | Completed |
| Planned — Approximate Date | ||||
6/8/2026 | 5.22K | $140.2K | Nasdaq | Planned |
| Total | 15.22K | $440.3K | ||